AN INNOVATIVE THERANOSTIC APPROACH TO TBI DRUB DEVELOPMENT: TBI BIOMARKERS-GUIDED NOVEL CALPAIN PROTEASE INHIBITO AS NEUROPROTECTANT WITH DRUGGABLE
$3,804,741FY2010Department of the ArmyDOD
Banyan Biomarkers, Inc., Alachua FL
Banyan Biomarkers, Inc., Alachua FL